Literature DB >> 23829995

Association of concurrent porcine circovirus (PCV) 2a and 2b infection with PCV associated disease in vaccinated pigs.

Priscilla F Gerber1, John Johnson, Huigang Shen, Dave Striegel, Chao-Ting Xiao, Patrick G Halbur, Tanja Opriessnig.   

Abstract

Investigations were performed to characterize porcine circovirus (PCV) 2 infection in 10 week old pigs from a case of apparent vaccine failure. Thirty serum samples were collected from affected or non-affected pigs and tested for anti-PCV2 antibodies and PCV2 DNA. To address potential PCV2 vaccine compliance issues, samples were tested for antibodies against baculovirus and Mycoplasma hyopneumoniae antigens present in the PCV2 vaccine utilized in this herd. Both PCV2a and PCV2b DNA were detected in 76.6% (90% positive for PCV2a, 86.6% positive for PCV2b), anti-PCV2 IgG in 90%, anti-baculovirus IgG in 50%, and anti-M. hyopneumoniae IgG in 43.3% of the samples. Frequency of baculovirus and M. hyopneumoniae seropositive pigs was significantly lower in affected pigs. The finding that only 50% of the pigs developed a detectable immune response to vaccination suggests poor vaccine compliance or efficacy. Concurrent PCV2a and PCV2b infection was common and may have resulted in enhanced PCV2 replication.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Co-infection; Porcine circovirus 2; Porcine circovirus associated disease

Mesh:

Substances:

Year:  2013        PMID: 23829995     DOI: 10.1016/j.rvsc.2013.06.004

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  6 in total

1.  Unusual outcome of in utero infection and subsequent postnatal super-infection with different PCV2b strains.

Authors:  Dipongkor Saha; Uladzimir U Karniychuk; Liping Huang; Marc Geldhof; Merijn Vanhee; David J Lefebvre; Peter Meerts; Richard Ducatelle; Jan V Doorsselaere; Hans J Nauwynck
Journal:  Virol Sin       Date:  2014-06-17       Impact factor: 4.327

2.  The evidence of occurrence of porcine circovirus 2 isolation and characterization in Kazakhstan.

Authors:  M Mambetaliyev; N B Yesimbekova; V M Strochkov; K K Tabynov; K T Sultankulova; Ye O Abduraimov
Journal:  Virusdisease       Date:  2018-02-17

Review 3.  Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology.

Authors:  Anbu K Karuppannan; Tanja Opriessnig
Journal:  Viruses       Date:  2017-05-06       Impact factor: 5.048

4.  Real-Time PCR Detection Patterns of Porcine Circovirus Type 2 (PCV2) in Polish Farms with Different Statuses of Vaccination against PCV2.

Authors:  Aleksandra Woźniak; Dagmara Miłek; Piotr Matyba; Tomasz Stadejek
Journal:  Viruses       Date:  2019-12-08       Impact factor: 5.048

5.  A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines.

Authors:  Meggan Bandrick; Monica Balasch; Andrea Heinz; Lucas Taylor; Vickie King; Jeri Toepfer; Dennis Foss
Journal:  Vet Res       Date:  2022-02-18       Impact factor: 3.683

6.  Mutant USA strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarean-derived, colostrum-deprived pigs.

Authors:  Tanja Opriessnig; Chao-Ting Xiao; Priscilla F Gerber; Patrick G Halbur; Shannon R Matzinger; Xiang-Jin Meng
Journal:  J Gen Virol       Date:  2014-07-22       Impact factor: 3.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.